Featured Research

from universities, journals, and other organizations

OHSU Team Discovers Compound That Lacks Estrogen's Risks

Date:
December 31, 2003
Source:
Oregon Health & Science University
Summary:
A team of Oregon Health & Science University researchers has discovered a compound that offers the benefits of estrogen but lacks the popular hormone replacement therapy's suspected side effects and risks.

PORTLAND, Ore. – A team of Oregon Health & Science University researchers has discovered a compound that offers the benefits of estrogen but lacks the popular hormone replacement therapy's suspected side effects and risks.

Scientists in the OHSU School of Medicine's Department of Physiology and Pharmacology, in collaboration with an organic chemist at the University of California, San Francisco, developed a new selective estrogen receptor modulator (SERM) called STX that shows promise as an alternative to estrogen treatment used by postmenopausal women to relieve symptoms of menopause, such as hot flashes and sleeplessness.

Martin J. Kelly, Ph.D., and Oline K. Rønnekleiv, Ph.D., professors of physiology and pharmacology at OHSU, led the team of investigators that discovered a novel estrogen signaling pathway in nerve cells in the brain. Their findings are published in the Oct. 22 edition of The Journal of Neuroscience.

"The function of STX was really identified from our electrophysiological assay based on testing different (SERM) compounds that acted like estrogen in the central nervous tissue, but not in other tissues susceptible to the cancer-causing effects of estrogens," Kelly said. Other compounds tested included the well-known SERMs tamoxifen and raloxifene, used for the prevention and treatment of breast cancer and osteoporosis, respectively.

STX mimics the effects of estrogen by activating a novel rapid signaling pathway, discovered by Kelly and Rønnekleiv, in nerve cells of the hypothalamus. The hypothalamus is a thumb-sized, central area on the underside of the brain that controls endocrine and autonomic functions, such as ovulation, lactation, stress responses, body temperature and energy balance.

Key to the development of STX was the work of organic chemist Thomas Scanlan, Ph.D., a UCSF professor whose laboratory synthesized the estrogen-like compounds tested in the electrophysiological assays used by Kelly and Rønnekleiv.

STX appears to act by stimulating a novel estrogen receptor, located in the cell membrane, that activates proteins involved in rapid cell signaling. In this way, it avoids the uterus and breasts, whose growth is stimulated by estrogen through a different pathway, leading to increased cancer risk.

The hypothalamus "controls all autonomic functions and maintains homeostasis – eating, drinking, sex behavior, maternal and even paternal behavior," Kelly said. In particular, hypothalamic POMC neurons, which are especially sensitive to STX, "are what activate the natural reward pathways. This is the brain's endogenous opiate system."

Having a selective estrogen trigger for rapid signaling is critical for estrogen replacement therapy, Kelly said. STX is structurally distinct from tamoxifen and raloxifene, and it's about 10 times more potent than estrogen and has the potential to be more effective at maintaining cognitive performance of postmenopausal women.

"Women that don't have hormone replacement therapy have been known to have more cognitive impairment in terms of loss of memory, and a higher incidence of Alzheimer's disease," Kelly said. "At least at the basic level, existing SERMs do not seem to help. So the search was on for other compounds one can use to replace tamoxifen. The collaboration with Dr. Scanlan at UCSF made it possible to synthesize and test a series of related compounds before we came up with STX."

Despite the discovery of STX, Rønnekleiv stopped short of rejecting estrogen as an effective therapy, saying its many benefits far outweigh the risks that studies have yet to unequivocally demonstrate.

"Estrogen definitely has neuroprotective effects in the brain," Rønnekleiv said. "At least in animal models, it's been shown that estrogen can reduce neuronal cell death from stroke. One of the other important actions of estrogen is to prevent osteoporosis."

Kelly's and Rønnekleiv's laboratories will continue to study the new signaling pathway, as well as the membrane estrogen receptor and its role in estrogen's many positive functions.

"We'd like to clone the receptor in order to effectively study its function, but we're not there yet," Kelly said. "That would be some time down the road, but with this new compound we now have a clear strategy for cloning this novel receptor."

Peter Kohler, M.D., an endocrinologist and president of OHSU, said the discovery of STX could lead to improvements in the quality of life for tens of thousands of women suffering from the uncomfortable symptoms of menopause.

"This drug has the potential to change the way we treat postmenopausal women," Kohler said. "It appears to be superior to other SERMS in efficacy and potency while avoiding the growth in the target tissues in which cancer risks are greatest."

But Kohler agreed that estrogen's many benefits can't be discounted. The new signaling pathway unveiled by the OHSU team demonstrates the hormone's importance to the brain in protecting itself from cell death caused by disease and the aging process. "Research is continuing, but this important discovery gives us a much better understanding of how the body responds to estrogen at the molecular level," he said.

Other study collaborators were: Jian Qiu, Ph.D., postdoctoral research fellow, Martha Bosch, research associate, and David Grandy, Ph.D., associate professor, OHSU; and Sandra Tobias, Ph.D., postdoctoral research fellow, UCSF Department of Pharmaceutical Chemistry. The study was supported by grants from the United States Public Health Service.


Story Source:

The above story is based on materials provided by Oregon Health & Science University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health & Science University. "OHSU Team Discovers Compound That Lacks Estrogen's Risks." ScienceDaily. ScienceDaily, 31 December 2003. <www.sciencedaily.com/releases/2003/12/031231082316.htm>.
Oregon Health & Science University. (2003, December 31). OHSU Team Discovers Compound That Lacks Estrogen's Risks. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2003/12/031231082316.htm
Oregon Health & Science University. "OHSU Team Discovers Compound That Lacks Estrogen's Risks." ScienceDaily. www.sciencedaily.com/releases/2003/12/031231082316.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins